Asia-Pacific Pharmaceutical Logistics Market Size (2024 - 2029)

The Asia-Pacific Pharmaceutical Logistics Market is experiencing significant growth, driven by increasing drug demand in emerging countries and rising healthcare expenditures across the region. This expansion is further fueled by the growing prevalence of chronic diseases and the rising use of generic substitutes. The market's rapid growth is also attributed to the strategic importance of logistics services for pharmaceutical companies, as they adapt to changing distribution needs. Additionally, the demand for herbal drugs in developing markets and the increase in prescriptions in developed economies are contributing to the market's expansion. The COVID-19 pandemic has also impacted the market, particularly in the cold chain sector, as manufacturers focus on storage solutions to extend product shelf life.

Market Size of Asia-Pacific Pharmaceutical Logistics Industry

Asia-Pacific Pharmaceutical Logistics Market Summary
Study Period 2019 - 2029
Base Year For Estimation 2023
Market Size (2024) USD 152.79 Billion
Market Size (2029) USD 211.16 Billion
CAGR (2024 - 2029) 6.68 %
Market Concentration Low

Major Players

Asia-Pacific Pharmaceutical Logistics Market Major Players

*Disclaimer: Major Players sorted in no particular order

Asia Pacific Pharmaceutical Logistics Market Analysis

The Asia-Pacific Pharmaceutical Logistics Market size is estimated at USD 152.79 billion in 2024, and is expected to reach USD 211.16 billion by 2029, growing at a CAGR of 6.68% during the forecast period (2024-2029).

  • The Asia-Pacific Pharmaceutical Logistics Market is rapidly growing due to the increasing drug demand from emerging countries. The number of patients in developed and developing regions is increasing rapidly, which in turn is impacting the existing pharmaceutical distribution channels. This has led to an increased demand for logistics services provided by pharma companies to meet this increasing need for supply management solutions.
  • The Asia-Pacific Pharmaceutical Logistics Market is the fastest-growing market in the pharmaceutical industry. The demand for pharmaceutical logistics services has been on the rise in recent times, emerging as a strategic business for drug manufacturers, distributors, retailers, and other players involved in the supply chain management of drugs.
  • The rise in demand is due to increasing healthcare expenditure across the region, coupled with the growing use of generic substitutes and increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular ailments like hypertension which are associated with high treatment costs.
  • The Asia Pacific Pharmacy Logistics Market is driven by the growth in demand for herbal drugs in developing markets such as China, India, and Japan, along with the increase in prescriptions across developed economies such as Australia, Hong Kong, South Korea, and Singapore.
  • Due to the COVID-19 pandemic's effects on the healthcare cold chain industry's supply chain and the pandemic's restrictions on commerce, cold chain manufacturers focused more on storage to extend their products' shelf lives, which was expected to fuel the market for cold chain expansion.

Asia Pacific Pharmaceutical Logistics Industry Segmentation

Pharmaceutical logistics is a method the healthcare system uses to ensure consistent support, a supply of medical tools and assistance, waste removal, cleaning, sterilization, and other relevant support activities for the control process.

Asia-Pacific Pharmaceutical Logistics Market report provides insights into the market Market Overview, Market Dynamics, Pharmaceutical Value Chain / Supply Chain Analysis, Technological Trends, Investment Scenarios, Government Regulations and Initiatives, Insights on the 3PL market in Asia-Pacific (Market Size and Forecast), Impact of Covid-19 on Pharmaceutical Logistics Market and Industry Attractiveness - Porter's Five Forces Analysis.

The Asia-Pacific Pharmaceutical Logistics market is segmented by product (Generic Drugs, Branded Drugs), by mode of operation (Cold Chain Transport, Non-Cold Chain Transport), by application (Bio Pharma, Chemical Pharma, Specialized Pharma), by mode of transport (Air, Rail, Road, and Sea) and by geography (China, India, Japan, South Korea, Singapore, Australia, and Rest of APAC). The report offers market size and forecast for Asia-Pacific Pharmaceutical Logistics Market in value (USD billion) for all the above segments.

By Product
Generic Drugs
Branded Drugs
By Mode of Operation
Cold Chain Transport
Non-Cold Chain Transport
By Application
Bio Pharma
Chemical Pharma
Specialized Pharma
By Mode of Transport
Air
Rail
Road
Sea
By Geography
China
India
Japan
South Korea
Singapore
Australia
Rest of Asia Pacific
Need A Different Region Or Segment?
Customize Now

Asia-Pacific Pharmaceutical Logistics Market Size Summary

The Asia-Pacific Pharmaceutical Logistics Market is experiencing rapid growth, driven by increasing drug demand from both emerging and developed countries. This surge in demand is largely due to the rising number of patients and the subsequent impact on pharmaceutical distribution channels, necessitating enhanced logistics services. The market is characterized by its strategic importance to drug manufacturers, distributors, and retailers, as they navigate the complexities of supply chain management. Factors such as increased healthcare expenditure, the growing use of generic drugs, and the prevalence of chronic diseases are contributing to the market's expansion. Additionally, the demand for herbal drugs and the rise in prescriptions across various economies are further propelling the market forward.

The market's growth is also influenced by the need for advanced cold chain logistics, particularly for temperature-sensitive healthcare products like vaccines and biopharmaceuticals. The COVID-19 pandemic has underscored the importance of cold chain infrastructure, leading to significant investments in storage and logistics capabilities. Countries like China, India, and Japan are becoming key players in the pharmaceutical logistics sector, with China and Japan's pharmaceutical industries gaining global prominence. The competitive landscape is marked by numerous participants, with companies prioritizing secure and cloud-based supply chain solutions to combat issues like counterfeit drugs. Major players in the market include Kuehne + Nagel, DB Schenker, DHL, and others, who are actively expanding their operations to meet the growing logistics demands in the region.

Explore More

Asia-Pacific Pharmaceutical Logistics Market Size - Table of Contents

  1. 1. MARKET INSIGHTS

    1. 1.1 Current Market Scenario

    2. 1.2 Pharmaceutical Value Chain / Supply Chain Analysis

    3. 1.3 Technological Trends

    4. 1.4 Investment Scenarios

    5. 1.5 Government Regulations and Initiatives

    6. 1.6 Insights on 3PL market in Asia-Pacific

    7. 1.7 Impact of COVID-19 on Pharmaceutical Logistics Market

  2. 2. MARKET SEGMENTATION

    1. 2.1 By Product

      1. 2.1.1 Generic Drugs

      2. 2.1.2 Branded Drugs

    2. 2.2 By Mode of Operation

      1. 2.2.1 Cold Chain Transport

      2. 2.2.2 Non-Cold Chain Transport

    3. 2.3 By Application

      1. 2.3.1 Bio Pharma

      2. 2.3.2 Chemical Pharma

      3. 2.3.3 Specialized Pharma

    4. 2.4 By Mode of Transport

      1. 2.4.1 Air

      2. 2.4.2 Rail

      3. 2.4.3 Road

      4. 2.4.4 Sea

    5. 2.5 By Geography

      1. 2.5.1 China

      2. 2.5.2 India

      3. 2.5.3 Japan

      4. 2.5.4 South Korea

      5. 2.5.5 Singapore

      6. 2.5.6 Australia

      7. 2.5.7 Rest of Asia Pacific

Asia-Pacific Pharmaceutical Logistics Market Size FAQs

The Asia-Pacific Pharmaceutical Logistics Market size is expected to reach USD 152.79 billion in 2024 and grow at a CAGR of 6.68% to reach USD 211.16 billion by 2029.

In 2024, the Asia-Pacific Pharmaceutical Logistics Market size is expected to reach USD 152.79 billion.

Asia Pacific Pharmaceutical Logistics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)